Documentos relacionados

1. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
2. Investigating paraneoplastic aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder through a data-driven approach.
3. Delivery of a therapeutic antibody to the lower gastrointestinal tract for the treatment of <i>Clostridium difficile</i> infection (CDI).
4. Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome.
5. Prediction of Human Pharmacokinetics of E0703, a Novel Radioprotective Agent, Using Physiologically Based Pharmacokinetic Modeling and an Interspecies Extrapolation Approach.
6. Albumin as a versatile platform for drug half-life extension.
7. Predicting successful/unsuccessful extrapolation for in vivo total clearance of model compounds with a variety of hepatic intrinsic metabolism and protein bindings in humans from pharmacokinetic data using chimeric mice with humanised liver.
8. Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice.
9. Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy.
10. Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver.